Exocrine pancreatic proteolytic activity, determined by serial measurement of faecal chymotrypsin concentration, was investigated in 21 preterm infants (23-32 weeks' gestation) during the first 28 days of life. The overall chymotrypsin concentration range was similar to that already described in term infants showing that pancreatic chymotrypsin secretion is equally well developed at birth in the preterm infant. A chymotrypsin concentration peak, seen in term infants at 4 days, did not occur in this study until day 8, suggesting a slower initiation of pancreatic exocrine function in the preterm infant. Median faecal chymotrypsin concentrations, calculated for each baby using data from stools passed between day 2 and day 12 of life, were significantly lower in infants who were small for gestational age when compared with those who were an appropriate size for gestational age. The lower chymotrypsin concentration in infants who were small for gestational age suggests a deleterious effect of intrauterine growth retardation on pancreatic exocrine function which may be a factor in limiting postnatal catch up growth.
The effect of postnatal feeding and other environmental factors on the ontogeny of the gastrointestinal tract is clearly important for survival of the preterm neonate. This is even more important in preterm infants with intrauterine growth retardation who may be less able to absorb nutrients than appropriately grown infants,' and who may have suboptimal growth throughout life. Such children are three times more likely than non-growth retarded babies to die during the first year of life.2 It has been suggested that by compromising nutrient digestion and absorption, intrauterine growth retardation may play an important part in subsequent poor postnatal growth.3 While few data are available from studies in humans, animal investigations have shown a clear association between intrauterine growth retardation and depression of exocrine pancreatic function. 4 Severely affected infants may therefore suffer an additional disadvantage through relative pancreatic exocrine insufficiency.
Intraduodenal tests are the most accurate method for determining exocrine pancreatic function,5 but they are clearly inappropriate for repeated investigation of preterm neonates being invasive, expensive, and technically complex. In contrast, faecal chymotrypsin measurement is non-invasive, cheap and simple, 6 and it is therefore ideal for repeated use in longitudinal studies. A recent study from this department has shown that there is a strong positive correlation between apparent pancreatic chymotrypsin and trypsin secretion rates after intravenous pancreozymin-secretin and faecal chymotrypsin concentrations. 7 We have therefore used serial measurements of chymotrypsin concentrations in stool to investigate the development of pancreatic secretory capacity over the first few weeks of life in preterm neonates who were either appropriate (AGA) or small for gestational age (SGA).
Subjects and methods
Twenty one preterm infants of 32 weeks' gestation or less (median gestational age 30 weeks, range 23-32), consecutively admitted to a regional neonatal intensive care unit, were included in the study from birth. The median birth weight was 1210 g (range 590-2100). Fourteen infants were normally grown (AGA), while seven showed evidence of intrauterine malnutrition with weight less than the 10th centile for gestational age (SGA). Gestational ages in the infants in the AGA group (26-32 weeks) and SGA group (23-32 weeks) were similar (p>0-1). The assessment of gestational age was based on clinical examination performed on the first day of life,8 together with reference to routine early antenatal ultrasonic measurements. 9 All infants received milk volumes related to their body weight: 60 ml/kg for the first two days of life, increasing by 30 ml/kg every two days to a total of 150 mg/kg. Five received only expressed breast milk; 16 were given breast milk followed by Premium (Cow and Gate) or Pregestimil (Mead Johnson). Two babies were given parenteral nutrition during part of the study period. Two developed necrotising enterocolitis during the four week study period. The results from infants with necrotising enterocolitis are included in this report but excluded from the SGA-AGA comparison.
STOOL COLLECTION AND ANALYTICAL METHODS
Stool specimens were collected daily during the first three weeks of life and then twice during the final week. Occasional days were omitted in most babies but all babies were studied for a minimum of 10 days. Seven patients were transferred back to referring hospitals before completion of four weeks. Specimens were collected in polystyrene Fecon stool containers, and stored at -20°C until analysed. Chymo-tryptic activity was measured using the Haverback kinetic potentiometric method.6 Details of the procedure as it was used, and performance data for the method, have been published previously.7
STATISTICAL EVALUATION
The results were evaluated using non-parametric tests. Spearman's rank correlation coefficient was used to determine the degree and significance of association between two measurements; the significance of the differences between groups was determined with the Mann-Whitney U test.
Results
Faecal chymotrypsin concentrations in the two babies in AGA group who had necrotising enterocolitis were clearly different from the rest of the patients studied, and they are therefore considered separately.
BABIES WITHOUT EVIDENCE OF NECROTISING ENTEROCOLITIS
A total of 305 random stool specimens were obtained from the 19 preterm neonates without necrotising enterocolitis studied. For any individual patient, results showed a wide scatter over the four week period but only 22 (7%) specimens produced a result below the lower reference limit of 120 jig chymotrypsin/g stool previously determined for neonates greater than 36 weeks' gestation.'0 Almost all of the low results occurred in the first few days of life with only one baby producing results below this limit after day 5.
BABIES WITH NECROTISING ENTEROCOLITIS
Fourteen (47%) of 30 results in the two babies who developed necrotising enterocolitis were below the lower reference limit of 120 ,ug chymotrypsin/g stool. One infant receiving breast milk had a low result on day 2, developed necrotising enterocolitis on day three of life, and was then intravenously fed until day 19 . Results above 120 ,ug/g stool were only seen from day 12 onwards. The second child was also fed with breast milk until signs of necrotising enterocolitis were noted on day 13, after which parenteral nutrition was given for six days. Daily stool chymotrypsin concentrations were below the lower reference limit up to day 5 and from days 8 to 13; concentrations were above the reference limit on day 6 (160 [ig/g), day 7 (360 [tg/g), and after day 14.
The random stool data from both the infants in the AGA and SGA groups (excluding the two babies with necrotising enterocolitis) were grouped into 24 hour periods (fig 1) and median values determined. The median concentration in babies in the AGA group increased steadily over the first week, reaching a peak value of 700 jig/g stool by day 8, followed by a decline over the next two to three days, falling to 320 ,ug/g stool by day 12. The median concentration in babies in the SGA group also increased over the (fig 2) . Four babies in the SGA group had birth weights (880-1340 g) within the range of the 12 babies in the AGA group (800-2110 g), but they had significantly lower median chymotrypsin concentrations (p=0-01). When median chymotrypsin concentrations between 2 and 12 days in both groups of infants were compared, those in the SGA group were shown to have significantly lower values (p<0-01). Median concentrations calculated for the period 13-29 days (fig 3) showed that the differences between the two, now smaller, groups was sustained (p=0004). Two babies who were partly parenterally fed had stool chymotrypsin values within the range observed for the rest of the group.
Discussion
The daily ranges of faecal chymotrypsin concentration determined in this study were similar to those described in term infants, only a few results falling below the term infant reference rangel' during the first four days of life in the babies in the AGA group, and over the first nine days of life in those in the SGA group.
The daily median chymotrypsin concentration for both groups of babies increased steadily after birth reaching a peak at six days and eight days respectively. A similar peak has been reported in term infants but occurred at four days of age.'0 As 
